Literature DB >> 21657837

The need for personalized therapy and companion diagnostics in prostate cancer.

Richard J Ablin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21657837     DOI： 10.2217/bmm.11.42

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  2 in total

1.  Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats.

Authors:  Kun Huang; Xiaowen Kang; Xinyan Wang; Shijie Wu; Jinling Xiao; Zhaoguo Li; Xiaomei Wu; Wei Zhang
Journal:  Mol Med Rep       Date:  2014-11-19       Impact factor: 2.952

2.  Mapping genetic variability in mature miRNAs and miRNA binding sites in prostate cancer.

Authors:  Bongyong Lee; Jian-Liang Li; John Marchica; Mark Mercola; Vipul Patel; Ranjan J Perera
Journal:  J Hum Genet       Date:  2021-06-08       Impact factor: 3.172
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.